Onconetix, Inc.

Healthcare · Biotechnology · United States

Last price 0.586 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.31M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Bl...